PRESS RELEASE published on 10/20/2023 at 15:40, 3 years ago Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG
PRESS RELEASE published on 10/20/2023 at 15:18, 3 years ago EQS-Adhoc: Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical Assets
PRESS RELEASE published on 10/17/2023 at 16:57, 3 years ago EQS-Adhoc: Eckert & Ziegler Achieves Double-Digit Growth in Q3 versus Previous Year. Significant Jump in Sales also in First 9 Months, Earnings still Burdened by Special Items Compared to Same Period Last Year.
PRESS RELEASE published on 10/10/2023 at 15:00, 3 years 1 month ago Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
PRESS RELEASE published on 09/28/2023 at 10:00, 3 years 1 month ago Eckert & Ziegler Receives Award for Professional Training
PRESS RELEASE published on 09/25/2023 at 23:17, 3 years 1 month ago EQS-Adhoc: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma
PRESS RELEASE published on 09/13/2023 at 15:00, 3 years 1 month ago Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
PRESS RELEASE published on 08/10/2023 at 07:45, 3 years 3 months ago Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
PRESS RELEASE published on 07/21/2023 at 15:21, 3 years 3 months ago EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
PRESS RELEASE published on 06/08/2023 at 11:31, 3 years 5 months ago Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
Published on 11/11/2026 at 03:30, 4 hours 32 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 7 hours 22 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 8 hours 32 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 9 hours 2 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 9 hours 2 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 07:30, 32 minutes ago GESCO reports significant increase in earnings in the first nine months and shows stable business performance in a challenging market environment
Published on 11/11/2026 at 07:30, 32 minutes ago voestalpine: voestalpine with solid results in the first half of 2026/27
Published on 11/11/2026 at 07:30, 32 minutes ago SFC Energy AG publishes nine-month report – record quarter in Q3, strong profitable growth and favourable product mix result in disproportionately strong earnings performance
Published on 11/11/2026 at 07:30, 32 minutes ago hGears Group delivers results in line with expectations in the first nine months of 2026
Published on 11/11/2026 at 07:30, 32 minutes ago VINCORION significantly increases revenue in the first nine months of 2026 and confirms raised full-year guidance
Published on 11/10/2026 at 18:00, 14 hours 2 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 14 hours 17 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 14 hours 27 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 14 hours 30 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
